Fracture WristNCT04848818
Comparative Trial of Operative Treatment of Distal Pediatric Forearm Fractures With Biodegradable Nails and K-wires
A study testing Distal radial metaphyseal fracture fixation with percutaneous K-wires and Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants in people with Fracture Wrist, run by Péterfy Sándor Hospital at 4 sites in Hungary.
Trial summary
The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. Read more about this study
- Who is it for?
- Ages 3 to 13 years
- Conditions the study is for
- Fracture Wrist
- What is being tested?
- Distal radial metaphyseal fracture fixation with percutaneous K-wires and Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 164 participants
- Where
- 4 sitesHungary
- Study dates
- 1 Mar 2020to Oct 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 13 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Clinical diagnosis of distal radial or complete forearm fracture Metaphyseal radial/or distal forearm fractures with complete displacement and shortening.
- Age between of 3-13 years. Open physeal plates on X-rays. Closed or Grade I. open fractures Ability and willingness to give an informed consent
Who cannot join
- Pathological fractures (e.g. bone cyst) Poly-traumatized patient Inability or unwillingness to give informed consent Closed physeal plates on X-rays. Active skin infection in the surgical area
Trial locations and contacts
4 sites in 1 country.
Hungary4 sites, 4 recruiting
- Recruiting
Szent János Hospital
Budapest, Diós Árok 1., 1125
András Petrovics, MD, 0036309817337, afeso4@gmail.com
Tamás Mona, MD, 0036209965234, monatamas@gmail.com
- Recruiting
Péterfy Hospital
Budapest, Fiumei Út 17, 1081
Marcell Varga, PhD, 0036709323027, drvmarcell@gmail.com
- Recruiting
Heim Pál Hospital
Budapest, Üllöi Út 86, 1089
Rita Varga, MD, 0036303306445, ritusvarga@citromail.hu
Zoltán Ringwald, MD, 0036204032800, ringwaldzoltan@gmail.com
- Recruiting
Medical University of Pécs, Pediatric Surgery
Pécs, József Attila U 7., 7623
Gergő Józsa, PhD, 0036305142730, dr.jozsa.gergo@gmail.com
About this study
Official title: Multicenter Prospective Trial for Operative Treatment of Distal Pediatric Forearm Fractures With PLGA-based Biodegradable Material (Activa Im-Nails™) and Conventional Implants (K-wires)
The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. The primary objective of the trial is to evaluate clinical outcome between Activa IM-Nail™ and K-wire in this indication. The secondary objective is to evaluate potential differences of potential complications in the operative method with either a biodegradable intramedullary PLGA-implant or with conventional K-wires. K-wire osteosynthesis will be made according to the conventional surgical technique by three paediatric trauma centers. Intramedullary PLGA implantation will be made by the Péterfy Hospital. The surgical indication will be the same in all groups, and follow-up will follow standard protocols. In the further clinical course, the patients in the study group treated with PLGA implants spare a subsequent operation for implant removal after 4-8 weeks. The results of different surgeries will be compared based on several criteria.
Read the detailed description
Over the last decade, there has been an increasing demand to overcome the disadvantages associated with conventional implant materials, by developing new, alternative materials and material production approaches for use in trauma care.
In recent years there has been a growing interest in the orthopaedic application of resorbable implants. Their use in children may be particularly beneficial. Poly(L-lactide)-co-glycolide acid (PLGA) is a well-known, reliable biodegradable material that has been used in bone surgery for more than 20 years. Several publications have already reported the successful use of intra-medullar PLGA implants in the treatment of paediatric diaphyseal forearm fractures.
To gather further evidence about the clinical value of the new method with PLGA - based bioresorbable implant in regard to patients benefit, a multicenter prospective trial is needed. This trial will be conducted on the distal forearm, which is one of the most common fracture locations that requires surgical intervention in children. Severely displaced distal paediatric forearm fractures will be addressed.
Distal paediatric forearm injuries
Distal radius fractures are among the most common injuries of childhood. Optimal treatment for distal radius fractures is still controversial. Treatment of severely displaced and shortened fractures usually require general narcosis and closed reduction. Most authors recommend osteosynthesis if the fracture remains unstable after reduction. The gold standard operative method for these fractures is closed reduction, percutaneous pinning with Kirschner-wires.
Kirschner-wire related minor complications are relatively frequent. Migration of the pins, superficial infections, skin irritation are well manageable but significantly impair the child's sense of comfort. Deep infections, tendon or nerve injuries may occur less often. There is a controversy as to whether it is preferable to leave the wires outside the skin. While wires left out of the skin increase the risk of infection, wires buried under the skin can be removed with a second intervention. Removing the implants can also cause complications.
K-wires are not capable of providing sufficient stabilization in this indication, so additional casting treatment is also required. The duration and the type of postoperative immobilization varies greatly according to the practice of the surgeons. There is no evidence about the most optimal immobilization procedure. 4-6 weeks of cast wearing is recommended by most authors. This causes stiffness in the affected joints and delays the recovery of full function. Fractures with intramedullary elastic nails require a reduced time of immobilization because they provide a more stable synthesis, but nails can be removed only under general anaesthesia. The use of bioabsorbable intramedullary nails in distal paediatric forearm fractures may eliminate all of the above-mentioned disadvantages.
The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. The primary objective of the trial is to evaluate clinical outcome between Activa IM-Nail™ and K-wire in this indication. The secondary objective is to evaluate potential differences of potential complications in the operative method with either a biodegradable intramedullary PLGA-implant or with conventional K-wires. K-wire osteosynthesis will be made according to the conventional surgical technique by two paediatric trauma centers. Intramedullary PLGA implantation will be made by the Péterfy Hospital. The surgical indication will be the same in all groups, and follow-up will follow standard protocols. In the further clinical course, the patients in the study group treated with PLGA implants spare a subsequent operation for implant removal after 4-8 weeks. The results of different surgeries will be compared based on several criteria.
- Conditions
- Fracture Wrist
- Being tested
- Distal radial metaphyseal fracture fixation with percutaneous K-wires, Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants
- Keywords
- children, radius, fracture, wire, bioabsorbable
- Medical subject headings
- Wrist Fractures, Fractures, Bone
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Distal radial metaphyseal fracture fixation with percutaneous K-wiresProcedure or surgery
Pediatric distal metaphyseal fractures which are severly displaced will be operated with percutaneous K-wires..
Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implantsProcedure or surgery
Pediatric distal metaphyseal radial and /or ulnar fractures which are severly displaced will be operated with percutaneous bidegradable PLGA-based (Activa Im-Nail) implants.
| Study group | Role | What they receive |
|---|---|---|
| K-wire group | Active comparator | Children with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13. Receives: Procedure: Distal radial metaphyseal fracture fixation with percutaneous K-wires |
| Activa-IM Nail group | Active comparator | Children with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13. Receives: Procedure: Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants |
What is being measured
The primary outcome is the main question the study is designed to answer.
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ correlate to less complications than the conventional K- wiring technique in displaced pediatric distal forearm or radial metaphyseal fractures?
We compare the incidence of minor and major complications of both surgical technique. These are: superficial skin infection, tendon injury, nerve injury, secondary displacement, deep infection, skin irritation.
Measured: Six months after operation
Secondary outcomes (5)
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ also reduce the postoperative immobilisation time?
Calculation of postoperative immobilisation time in weeks. Calculation and comparison the necessary immobilisation times in both surgical techniques.
Measured: Eight weeks after operation
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ not require a second intervention?
Calculation and comparioson of the number of a second operative intervention in both surgical techniqes.
Measured: Six months after operation
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ also reduce the postoperative outpatient visits?
Calculation and comparison the number of postoperative outpatient visits in both surgical techniques.
Measured: 1 year after operation
Does the short intramedullary nailing operative method with biodegradable nails and K-wire technique results a full recovery of the functions within six months?
Examination by the range of motion method (ROM) of the wrists of the patients. Full recovery means , that the range of pronation/supination and flexion/extension of the wrist will be the same as the range of the healthy side.The examination is also performed at weeks 4,8,and 24.
Measured: Six months after operation
Does the short intramedullary nailing operative method with biodegradable nails shortens the recovery time for the full function compared to the K-wiring method?
Based on the results of ROM -method examinations performed at weeks 4,8 and 24 weeks ,we compare and calculate the difference in the rates of function recovery in both surgical technique.
Measured: Six months after surgey
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Apr 2021
- Study start1 Mar 2020
- Primary completionMar 2022 (estimated)
- Study completionOct 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Fracture WristStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 164 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Péterfy Sándor Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Marcell Varga, PhD, Principal investigator, Péterfy Hospital, National Trauma Center,Budapest
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04848818
- Sponsor's protocol ID
- 228-01-CIP-3
- Status last verified
- Mar 2021
- First submitted
- 8 Apr 2021
- Last updated
- 19 Apr 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multicenter Prospective Trial for Operative Treatment of Distal Pediatric Forearm Fractures With PLGA-based Biodegradable Material (Activa Im-Nails™) and Conventional Implants (K-wires)
- ClinicalTrials.gov ID
- NCT04848818
- Acronym / sponsor ID
- 228-01-CIP-3
- Conditions
- Fracture Wrist
- Keywords
- children, radius, fracture, wire, bioabsorbable
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 164 participants (estimated)
- Lead sponsor
- Péterfy Sándor HospitalUniversity, hospital or other
- Study start
- 1 Mar 2020 (actual)
- Primary completion
- Mar 2022 (estimated)
- Study completion
- Oct 2022 (estimated)
- First posted
- 19 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. The primary objective of the trial is to evaluate clinical outcome between Activa IM-Nail™ and K-wire in this indication. The secondary objective is to evaluate potential differences of potential complications in the operative method with either a biodegradable intramedullary PLGA-implant or with conventional K-wires. K-wire osteosynthesis will be made according to the conventional surgical technique by three paediatric trauma centers. Intramedullary PLGA implantation will be made by the Péterfy Hospital. The surgical indication will be the same in all groups, and follow-up will follow standard protocols. In the further clinical course, the patients in the study group treated with PLGA implants spare a subsequent operation for implant removal after 4-8 weeks. The results of different surgeries will be compared based on several criteria.
Detailed description
Over the last decade, there has been an increasing demand to overcome the disadvantages associated with conventional implant materials, by developing new, alternative materials and material production approaches for use in trauma care.
In recent years there has been a growing interest in the orthopaedic application of resorbable implants. Their use in children may be particularly beneficial. Poly(L-lactide)-co-glycolide acid (PLGA) is a well-known, reliable biodegradable material that has been used in bone surgery for more than 20 years. Several publications have already reported the successful use of intra-medullar PLGA implants in the treatment of paediatric diaphyseal forearm fractures.
To gather further evidence about the clinical value of the new method with PLGA - based bioresorbable implant in regard to patients benefit, a multicenter prospective trial is needed. This trial will be conducted on the distal forearm, which is one of the most common fracture locations that requires surgical intervention in children. Severely displaced distal paediatric forearm fractures will be addressed.
Distal paediatric forearm injuries
Distal radius fractures are among the most common injuries of childhood. Optimal treatment for distal radius fractures is still controversial. Treatment of severely displaced and shortened fractures usually require general narcosis and closed reduction. Most authors recommend osteosynthesis if the fracture remains unstable after reduction. The gold standard operative method for these fractures is closed reduction, percutaneous pinning with Kirschner-wires.
Kirschner-wire related minor complications are relatively frequent. Migration of the pins, superficial infections, skin irritation are well manageable but significantly impair the child's sense of comfort. Deep infections, tendon or nerve injuries may occur less often. There is a controversy as to whether it is preferable to leave the wires outside the skin. While wires left out of the skin increase the risk of infection, wires buried under the skin can be removed with a second intervention. Removing the implants can also cause complications.
K-wires are not capable of providing sufficient stabilization in this indication, so additional casting treatment is also required. The duration and the type of postoperative immobilization varies greatly according to the practice of the surgeons. There is no evidence about the most optimal immobilization procedure. 4-6 weeks of cast wearing is recommended by most authors. This causes stiffness in the affected joints and delays the recovery of full function. Fractures with intramedullary elastic nails require a reduced time of immobilization because they provide a more stable synthesis, but nails can be removed only under general anaesthesia. The use of bioabsorbable intramedullary nails in distal paediatric forearm fractures may eliminate all of the above-mentioned disadvantages.
The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. The primary objective of the trial is to evaluate clinical outcome between Activa IM-Nail™ and K-wire in this indication. The secondary objective is to evaluate potential differences of potential complications in the operative method with either a biodegradable intramedullary PLGA-implant or with conventional K-wires. K-wire osteosynthesis will be made according to the conventional surgical technique by two paediatric trauma centers. Intramedullary PLGA implantation will be made by the Péterfy Hospital. The surgical indication will be the same in all groups, and follow-up will follow standard protocols. In the further clinical course, the patients in the study group treated with PLGA implants spare a subsequent operation for implant removal after 4-8 weeks. The results of different surgeries will be compared based on several criteria.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| K-wire group | Active comparator | Procedure: Distal radial metaphyseal fracture fixation with percutaneous K-wiresChildren with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13. |
| Activa-IM Nail group | Active comparator | Procedure: Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implantsChildren with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13. |
Who may qualify
- Ages
- 3 to 13 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- Clinical diagnosis of distal radial or complete forearm fracture Metaphyseal radial/or distal forearm fractures with complete displacement and shortening.
- Age between of 3-13 years. Open physeal plates on X-rays. Closed or Grade I. open fractures Ability and willingness to give an informed consent
Key exclusion criteria (1 listed)
- Pathological fractures (e.g. bone cyst) Poly-traumatized patient Inability or unwillingness to give informed consent Closed physeal plates on X-rays. Active skin infection in the surgical area
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Distal radial metaphyseal fracture fixation with percutaneous K-wiresPediatric distal metaphyseal fractures which are severly displaced will be operated with percutaneous K-wires.. | Procedure or surgery | K-wire group |
| Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implantsPediatric distal metaphyseal radial and /or ulnar fractures which are severly displaced will be operated with percutaneous bidegradable PLGA-based (Activa Im-Nail) implants. | Procedure or surgery | Activa-IM Nail group |
Primary outcome
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ correlate to less complications than the conventional K- wiring technique in displaced pediatric distal forearm or radial metaphyseal fractures?
Time frame: Six months after operation
We compare the incidence of minor and major complications of both surgical technique. These are: superficial skin infection, tendon injury, nerve injury, secondary displacement, deep infection, skin irritation.
5 secondary outcomes
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ also reduce the postoperative immobilisation time?
Time frame: Eight weeks after operation
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ not require a second intervention?
Time frame: Six months after operation
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ also reduce the postoperative outpatient visits?
Time frame: 1 year after operation
Does the short intramedullary nailing operative method with biodegradable nails and K-wire technique results a full recovery of the functions within six months?
Time frame: Six months after operation
Does the short intramedullary nailing operative method with biodegradable nails shortens the recovery time for the full function compared to the K-wiring method?
Time frame: Six months after surgey
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Apr 2021.
- Individual participant dataSharing planned: No
Related trials for Fracture Wrist
Recruiting
No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older
Distal Radius Fracture, Casting
Active, not recruiting
Immediate Mobilization Versus 2 Weeks Cast Immobilization After Distal Radius Fracture Treated With Volar Locking Plate
Distal Radius Fracture
Recruiting
Wrist Injury Strengthening Exercise (WISE) Versus Usual Care Advice for Improving Pain and Function
Distal Radius Fracture, Colles Fracture
Not yet recruiting
One Inch Punch High Impact Training Randomized Control Trial (1'' Punch HIT RCT)
Distal Radius Fracture
Not yet recruiting
Magnesium Alloy Scaffold With Controlled Degradation for Periarticular Bone Defects
Periarticular Bone Defect, Proximal Humerus Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marcell Varga, PhD principal investigator
Péterfy Hospital, National Trauma Center,Budapest
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Distal radial metaphyseal fracture fixation with percutaneous K-wires and Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants in people with Fracture Wrist, run by Péterfy Sándor Hospital at 4 sites in Hungary.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marcell Varga, PhD (0036709323027, drvmarcell@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ correlate to less complications than the conventional K- wiring technique in displaced pediatric distal forearm or radial metaphyseal fractures? (time frame: Six months after operation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2021; AzTrials last refreshed its copy on 8 Nov 2026.